Loading company…
Synteract is a Carlsbad contract research organization providing clinical trial and regulatory services to drug developers.
Founded in 1986 in Carlsbad, US, Synteract, Inc. provides clinical development, regulatory affairs, drug safety and clinical trial management services to pharmaceutical and biotechnology companies. Syneos Health acquired the company in December 2020 from Amulet Capital Partners for an undisclosed amount. A Secondary Buyout led by Amulet Capital Partners is recorded as its latest round, with a total amount raised of USD 1500.00 mn. The listed stage is Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in